References
- Pappa V, Papageorgiou S, Kontsioti E, Papageorgiou E, Tsiotra P, Dervenoulas J, et al. Internal tandem duplication of FLT3 gene can be detected in low-risk myelodysplastic syndromes. Leuk Lymphoma 2007; 48: 2437–2440
- Nakao M, Yokota S, Iwai T, Kaneko H, Horiike S, Kashima K, et al. Internal tandem duplication of the FLT3 gene found in acute myeloid leukemia. Leukemia 1996; 10: 1911–1918
- Abu-Duhier F M, Goodeve A C, Wilson G A, Gari M A, Peake I R, Rees D C, et al. FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group. Br J Haematol 2000; 111: 190–195
- Horiike S, Yokota S, Nakao M, Iwai T, Sasai Y, Kaneko H, et al. Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia. Leukemia 1997; 11: 1442–1446
- Au W Y, Fung A T, Ma E S, Liang R H, Kwong Y L. Low frequency of FLT3 gene internal tandem duplication and activating loop mutation in therapy-related acute myelocyticleukemia and myelodysplastic syndrome. Cancer Genet Cytogenet 2004; 149: 169–172
- Georgiou G, Karali V, Zouvelou C, Kyriakou E, Dimou M, Chrisochoou S, et al. Serial determination of FLT3 mutations in myelodysplastic syndrome patients at diagnosis, follow-up or acute myeloid leukaemia transformation: incidence and their prognostic significance. Br J Haematol 2006; 134: 302–306
- Bacher U, Haferlach T, Kern W, Haferlach C, Schnittger S. A comparative study of molecular mutations in 381 patients with myelodysplastic syndrome and in 4130 patients with acute myeloid leukemia. Haematologica 2007; 92: 744–752
- Kottaridis P D, Gale R E, Langabeer S E, Frew M E, Bowen D T, Linch D C. Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors. Blood 2002; 100: 2393–2398
- Moore M A, Dorn D C, Schuringa J J, Chung K Y, Morrone G. Constitutive activation of FLT3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells. Exp Hematol 2007; 35: 105–116
- Libura M, Asnafi V, Tu A, Delabesse E, Tigaud I, Cymbalista F, et al. FLT3 and MLL intragenic abnormalities in AML reflect a common category of genotoxic stress. Blood 2003; 102: 2198–2204
- Seedhouse C H, Hunter H M, Lloyd-Lewis B, Massip A M, Pallis M, Carter G I, et al. DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412. Leukemia 2006; 20: 2130–2136